Xylo Technologies Ltd. - Asset Resilience Ratio
Xylo Technologies Ltd. (XYLO) has an Asset Resilience Ratio of 15.76% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Xylo Technologies Ltd. to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Xylo Technologies Ltd.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Xylo Technologies Ltd. (XYLO) total assets.
Liquid Assets Composition Over Time
This chart breaks down Xylo Technologies Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Xylo Technologies Ltd. strategic investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.92 Million | 15.76% |
| Total Liquid Assets | $5.92 Million | 15.76% |
Asset Resilience Insights
- Good Liquidity Position: Xylo Technologies Ltd. maintains a healthy 15.76% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Xylo Technologies Ltd. Industry Peers by Asset Resilience Ratio
Compare Xylo Technologies Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
LENSAR Inc
NASDAQ:LNSR |
Medical Devices | 0.00% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 14.18% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
Annual Asset Resilience Ratio for Xylo Technologies Ltd. (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Xylo Technologies Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.76% | $5.92 Million | $37.55 Million | +10.79pp |
| 2023-12-31 | 4.98% | $3.18 Million | $63.90 Million | -0.13pp |
| 2022-12-31 | 5.10% | $4.99 Million | $97.65 Million | -0.45pp |
| 2021-12-31 | 5.55% | $3.31 Million | $59.73 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $32.34 Million | -- |
| 2017-12-31 | 48.52% | $3.50 Million | $7.21 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more